Why Chemed Stock Is Plummeting Today
(NYSE: CHE) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market Intelligence.
Chemed reported second-quarter earnings that fell short of analysts' expectations, causing its share price to tumble.
While Chemed grew sales by 4% in Q2, adjusted earnings per share (EPS) declined by a staggering 22%. Meanwhile, management cut 2025 EPS guidance from $25.20 to $22.15, implying a 4% decline from last year's earnings.
Source Fool.com
Chemed Corp. Aktie
?
-0,56 %
Und die Aktie ist derzeit mit 9 Buy-Einschätzungen und keiner einzigen Sell-Einschätzung ein Geheimtipp unserer Community.
Eine Steigerung von über 20% ist für Chemed Corp. möglich, angesichts eines Kursziels von 515 € gegenüber 358.0 €.
